Search Medical Condition
Please enter condition
Please choose location from dropdown

Heartburn (Pediatric) Clinical Trials

A listing of Heartburn (Pediatric) medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.


Found (5) clinical trials

Study of Dietary Patterns and Food Diversity in Russian GERD Patients

The study of dietary patterns may provide complex vision of an association between consumption of specific foods, or groups of food products and manifestations of gastroesophageal reflux disease (symptoms: heartburn and acid regurgitation; endoscopic findings - oesophagitis). Only limited data on this matter are published to the moment and they ...

Phase N/A

Mipolixin Compared to Poliprotect in Moderate Functional Dyspepsia and Heartburn.

Evaluation of the clinical efficacy of two medical devices, Mipolixin and Poliprotect, in improving the overall symptom severity of functional dyspesia and/or heartburn

Phase N/A

Domperidone in Treating Patients With Gastrointestinal Disorders

PRIMARY OBJECTIVES: I. To provide treatment with domperidone to patients >= 16 years of age where, according to the investigators' judgment, a prokinetic effect is needed for the relief of gastrointestinal (GI) motility disorders. OUTLINE Patients receive domperidone orally (PO) thrice daily (TID) or four times daily (QID). Treatment continues ...


Citalopram for Reflux Hypersensitivity and Functional Heartburn

Citalopram is a drug used in the treatment of depressive episodes and belongs to the group of selective serotonin reuptake inhibitors (SSRI). Serotonin is an important neurotransmitter predominantly found in the brain and the gastrointestinal tract. Serotonin is associated with psychological disorders, including anxiety and depression, and emotion regulation and ...


Comparison of Nexium Versus Secretol in the Healing and Controlling of Symptoms in GERD Patients With Severe EE.

We hypothesize that Secretol 80/80 daily will demonstrate better efficacy than Nexium 40 mg daily in healing erosive esophagitis(EE)and controlling gastroesophageal reflux disease(GERD)related symptoms after 3 weeks of treatment.In addition, Secretol 80/80 daily will have a faster effect on the aforementioned clinical parameters but a similar safety profile.